Skip to main content
RadNet, Inc. (RDNT)
NASDAQ: RDNT · Real-Time Price · USD
72.70
+1.32 (1.85%)
At close: Dec 20, 2024, 4:00 PM
71.66
-1.04 (-1.43%)
After-hours: Dec 20, 2024, 4:50 PM EST

RadNet Revenue

RadNet had revenue of $461.14M in the quarter ending September 30, 2024, with 14.72% growth. This brings the company's revenue in the last twelve months to $1.77B, up 12.20% year-over-year. In the year 2023, RadNet had annual revenue of $1.62B with 13.05% growth.

Revenue (ttm)
$1.77B
Revenue Growth
+12.20%
P/S Ratio
2.93
Revenue / Employee
$210,040
Employees
8,441
Market Cap
5.38B

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 20231.62B186.57M13.05%
Dec 31, 20221.43B105.87M8.00%
Dec 31, 20211.32B226.08M20.59%
Dec 31, 20201.10B-56.08M-4.86%
Dec 31, 20191.15B179.03M18.36%
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro
Dec 31, 2014 Pro Pro Pro
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Alkermes 1.51B
Merit Medical Systems 1.33B
Inspire Medical Systems 755.59M
Tempus AI 640.44M
Corcept Therapeutics 628.56M
Telix Pharmaceuticals 430.80M
Krystal Biotech 241.52M
BridgeBio Pharma 217.77M
Revenue Rankings

RDNT News

More News